Armando Zuniga
CSO
Shape Biopharmaceuticals
Au ZH, Switzerland
10 profile visits
Co-founder and CSO of Shape Biopharmaceuticals. Dedicated to science since more than 25 years in the fields of vaccine development and active immunotherapy.
My organisation
Shape Biopharmaceuticals AG develops multi-target antibody-inducing immunotherapies using its fully synthetic SHAPEnano nanoparticle platform. The technology enables durable modulation of multiple pathways with ultra-low dosing and scalable peptide-like manufacturing. Our lead program targets PCSK9 and ANGPTL pathways for mixed hyperlipidemia, with in vivo proof-of-concept showing combined cholesterol and triglyceride lowering. We are advancing toward clinical candidate nomination and seek partners for R&D, EU projects, and translational development.